Penumbra Inc (PEN)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ONE PENUMBRA PLACE ALAMEDA, CA 94502

Penumbra, Inc. operates as an interventional therapies company. The Company designs, develops, manufactures, and markets medical devices worldwide. Penumbra offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases.

Data as of 2020-06-27
Market Cap6.134 Billion Shares Outstanding35.94 Million Avg 30-day Volume237.86 Thousand
P/E Ratio159.0 Dividend Yield EPS1.09
Price/Sales11.026 Price cash flow ratio276.0 Price free cash flow ratio-892.8
Book Value13.6 Price to Tangible Book13.65 Alpha
Short Interest Ratio12.38 % Short Interest to Float7.8 R-squared
BETA 52-week High/Low194.93 / 121.8 Stddev
View SEC Filings from PEN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 239 55 (3.6%)
Aggregate 13F shares on 03/31/2020: 29.33 Million 14.868 Million
Aggregate 13F shares on 12/31/2019: 30.076 Million 15.12 Million
Percent change: -2.48% -1.66%
Funds creating new positions: 33 7
Funds Adding to an existing position: 86 19
Funds closing out their position: 36 20
Funds reducing their position: 86 23
Heat Map Ranking for 03/31/2020 263
Heat Map Ranking for 12/31/2019 390
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

26 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KOSARAJU SRIDHAR

  • Director
0 2020-06-15 6

ELSESSER ADAM CEO AND PRESIDENT

  • Officer
  • Director
1,005,582 2020-06-11 11

ROBERTS JOHANNA EVP, GEN. COUNSEL & SECRETARY

  • Officer
52,761 2020-05-15 3

BOSE ARANI CHIEF INNOVATOR

  • Officer
  • Director
560,662 2020-05-07 4

O'ROURKE BRIDGET

  • Director
3,623 2020-04-06 4

KASSING DON W.

  • Director
10,205 2020-02-24 3

GREWAL HARPREET

  • Director
13,395 2020-02-11 4

ROTHMAN LYNN EVP AND CHIEF BUSINESS OFFICER

  • Officer
117,139 2020-02-11 8

WILDER THOMAS

  • Director
4,253 2020-02-11 4

LEEDS JANET

  • Director
2,716 2020-02-11 1

SARNA SURBHI

  • Director
1,791 2020-02-11 2

SHIU LAMBERT CHIEF ACCOUNTING OFFICER

  • Officer
10,849 2020-02-09 2

PRAY JAMES ROBERT PRESIDENT, INTERNATIONAL

  • Officer
455,009 2020-01-02 6

YUEN MAGGIE CHIEF FINANCIAL OFFICER

  • Officer
6,950 2019-12-16 2

DAVIS DANIEL DONEN SEE REMARKS

  • Officer
64,277 2018-12-27 0

EVANS ROBERT D. EVP, GEN. COUNSEL & SECRETARY

  • Officer
167,963 2018-08-29 0

SULLIVAN KEVIN JAMES

  • Director
29,449 2016-08-31 0

WANG WALTER CHARLES

  • Director
1,484,931 2016-03-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-06-11 S 300 $168.22 d 1,005,582 1,005,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-06-11 S 2,021 $167.31 d 1,005,882 1,005,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-06-11 S 5,679 $166.66 d 1,007,903 1,005,582.00 indirect yes

ROBERTS JOHANNA - Officer EVP, GEN. COUNSEL & SECRETARY

2020-05-15 F 1,295 $171.14 d 52,761 52,761.00 direct

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 400 $190.45 d 1,016,031 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 584 $187.45 d 1,017,577 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 1,150 $184.22 d 1,019,232 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 100 $181.85 d 1,021,282 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 1,949 $192.16 d 1,013,582 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 703 $189.18 d 1,016,431 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 600 $186.31 d 1,018,161 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 400 $183.35 d 1,020,382 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 200 $177.05 d 1,021,382 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 500 $191.42 d 1,015,531 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 443 $188.29 d 1,017,134 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 471 $185.33 d 1,018,761 1,013,582.00 indirect yes

ELSESSER ADAM - Director - Officer CEO AND PRESIDENT by trust

2020-05-11 S 500 $182.41 d 1,020,782 1,013,582.00 indirect yes

BOSE ARANI - Director - Officer CHIEF INNOVATOR

2020-05-07 S 10,000 $185.07 d 560,662 560,662.00 direct yes
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments